200 related articles for article (PubMed ID: 37469401)
21. Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report.
Hidaka Y; Tomita M; Desaki R; Hamanoue M; Takao S; Kirishima M; Ohtsuka T
World J Surg Oncol; 2022 Jul; 20(1):228. PubMed ID: 35831894
[TBL] [Abstract][Full Text] [Related]
22. Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma.
Wang SY; Su TH; Chen BB; Liu CJ; Liu CH; Yang HC; Tseng TC; Chen PJ; Kao JH
J Formos Med Assoc; 2022 Aug; 121(8):1579-1587. PubMed ID: 35078686
[TBL] [Abstract][Full Text] [Related]
23. Three decades' experience in surgery of hepatocellular carcinoma.
Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study.
Chen R; Li L; Li Y; Song K; Shen C; Ma P; Wang Z
J Gastrointest Oncol; 2022 Jun; 13(3):1367-1375. PubMed ID: 35837188
[TBL] [Abstract][Full Text] [Related]
25. Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma.
Scott A; Wong P; Melstrom LG
Surgery; 2023 Jul; 174(1):113-115. PubMed ID: 36906437
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
27. [Application of portal vein chemoembolization in major hepatectomy for initially unresectable primary and secondary hepatic tumors].
Jiang ZZ; Dai Y; Jiang XS; Zhu M; Zhang XG; Jian WC
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(8):532-4. PubMed ID: 21418854
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy.
Feng R; Cheng DX; Song T; Chen L; Lu KP
World J Gastrointest Surg; 2023 Apr; 15(4):687-697. PubMed ID: 37206075
[TBL] [Abstract][Full Text] [Related]
29. Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
Pan Y; Mei J; Chen J; Zhang D; Wang J; Wang X; Yi M; Zhou Z; Zhang Y; Chen M; Guo R; Xu L
Ann Surg Oncol; 2022 Mar; 29(3):2016-2029. PubMed ID: 34637058
[TBL] [Abstract][Full Text] [Related]
30. Adapting the Utility of Lipiodol CT in Treating Small Hepatocellular Carcinoma.
Paul SB; Gamanagatti SR; Dhamija E; Pulappadi VP; Shalimar ; Acharya SK
J Clin Exp Hepatol; 2022; 12(2):664-668. PubMed ID: 35535096
[TBL] [Abstract][Full Text] [Related]
31. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma.
Liu BJ; Gao S; Zhu X; Guo JH; Zhang X; Chen H; Wang XD; Yang RJ
World J Gastrointest Oncol; 2020 Jun; 12(6):663-676. PubMed ID: 32699581
[TBL] [Abstract][Full Text] [Related]
32. Downstaging of Recurrent Advanced Hepatocellular Carcinoma After Lenvatinib Treatment: Opportunities or Pitfalls? A Case Report.
Liu Z; Fu Z; Li G; Lin D
Onco Targets Ther; 2020; 13():10267-10273. PubMed ID: 33116607
[TBL] [Abstract][Full Text] [Related]
33. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
Liu BJ; Gao S; Zhu X; Guo JH; Kou FX; Liu SX; Zhang X; Wang XD; Cao G; Chen H; Liu P; Zhu LZ; Xu HF; Yang RJ
Biomed Res Int; 2021; 2021():6670367. PubMed ID: 34337041
[TBL] [Abstract][Full Text] [Related]
34. Two hepatectomy cases for initially unresectable hepatocellular carcinoma after achieving a radiological complete response to sequential therapy with lenvatinib and transcatheter arterial chemoembolization.
Endo K; Kuroda H; Abe T; Sato H; Kooka Y; Oikawa T; Sato A; Nishiya M; Sugai T; Takikawa Y
Hepatol Res; 2021 Oct; 51(10):1082-1086. PubMed ID: 33982336
[TBL] [Abstract][Full Text] [Related]
35. Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case.
Itoh A; Sadamori H; Yabushita K; Monden K; Tatsukawa M; Hioki M; Hyodo T; Omonishi K; Ueki T; Ohno S; Sakaguchi K; Takakura N
BMC Cancer; 2016 Sep; 16(1):705. PubMed ID: 27586890
[TBL] [Abstract][Full Text] [Related]
36. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report.
Sano S; Nakata S; Wada S; Kuroiwa M; Sakai H; Kusama K; Machida T; Nishio A; Ito I; Sodeyama H
World J Surg Oncol; 2019 Dec; 17(1):229. PubMed ID: 31878937
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of hepatic arterial infusion chemotherapy combined with transarterial embolization for unresectable hepatocellular carcinoma: A propensity score-matching cohort study.
Guo W; Gao J; Zhuang W; Wu Z; Li B; Chen S
JGH Open; 2020 Jun; 4(3):477-483. PubMed ID: 32514457
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment with laparoscopic surgery and sequential multikinase inhibitor therapy for hepatocellular carcinoma: A case report.
Endo Y; Shimazu M; Sakuragawa T; Uchi Y; Edanami M; Sunamura K; Ozawa S; Chiba N; Kawachi S
World J Gastrointest Surg; 2022 Mar; 14(3):260-267. PubMed ID: 35432767
[TBL] [Abstract][Full Text] [Related]
39. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
[TBL] [Abstract][Full Text] [Related]
40. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
